[CYCC] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
05-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -21.15%
YoY- -14.12%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,537 -2,452 -1,510 -2,752 -2,174 -2,090 -2,110 13.03%
Tax -281 -286 -290 -449 -273 -307 -268 3.19%
NP -2,256 -2,166 -1,220 -2,303 -1,901 -1,783 -1,842 14.42%
Tax Rate - - - - - - - -
Total Cost 2,256 2,166 1,220 2,303 1,901 1,783 1,842 14.42%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.46 -0.56 -1.42 -2.68 -2.21 -2.07 -2.70 -69.16%
EPS Diluted -0.46 -0.56 -1.42 -2.68 -2.21 -2.07 -2.70 -69.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.